BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23659506)

  • 21. Endoscopic findings corresponding to multiple Lugol-voiding lesions in the esophageal background mucosa.
    Matsuno K; Ishihara R; Nakagawa K; Ohmori M; Iwagami H; Inoue S; Iwatsubo T; Nakahira H; Matsuura N; Shichijyo S; Maekawa A; Takashi K; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Matsunaga T
    J Gastroenterol Hepatol; 2019 Feb; 34(2):390-396. PubMed ID: 30101499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Narrow-band imaging without magnification for detecting early esophageal squamous cell carcinoma.
    Ide E; Maluf-Filho F; Chaves DM; Matuguma SE; Sakai P
    World J Gastroenterol; 2011 Oct; 17(39):4408-13. PubMed ID: 22110267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Narrow band imaging versus lugol chromoendoscopy to diagnose squamous cell carcinoma of the esophagus: a systematic review and meta-analysis.
    Morita FH; Bernardo WM; Ide E; Rocha RS; Aquino JC; Minata MK; Yamazaki K; Marques SB; Sakai P; de Moura EG
    BMC Cancer; 2017 Jan; 17(1):54. PubMed ID: 28086818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transnasal endoscopy with narrow-band imaging and Lugol staining to screen patients with head and neck cancer whose condition limits oral intubation with standard endoscope (with video).
    Lee YC; Wang CP; Chen CC; Chiu HM; Ko JY; Lou PJ; Yang TL; Huang HY; Wu MS; Lin JT; Hsiu-Hsi Chen T; Wang HP
    Gastrointest Endosc; 2009 Mar; 69(3 Pt 1):408-17. PubMed ID: 19019362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis of superficial esophageal cancer and dysplasia using endoscopic screening with a 2% lugol dye solution in patients with head and neck cancer.
    Tincani AJ; Brandalise N; Altemani A; Scanavini RC; Valério JB; Lage HT; Molina G; Martins AS
    Head Neck; 2000 Mar; 22(2):170-4. PubMed ID: 10679905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of superficial squamous cell carcinoma developing in the head and neck region in patients with esophageal squamous cell carcinoma.
    Katada C; Muto M; Nakayama M; Tanabe S; Higuchi K; Sasaki T; Azuma M; Ishido K; Katada N; Yamashita K; Nemoto M; Shibata T; Masaki T; Okamoto M; Koizumi W
    Laryngoscope; 2012 Jun; 122(6):1291-6. PubMed ID: 22674532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic accuracy of probe-based confocal laser endomicroscopy in Lugol-unstained esophageal superficial lesions of patients with head and neck cancer.
    Safatle-Ribeiro AV; Baba ER; Faraj SF; Rios JT; de Lima MS; Martins BC; Geiger SN; Pennacchi C; Gusman C; Kawaguti FS; Uemura RS; de Melo ES; Ribeiro U; Maluf-Filho F
    Gastrointest Endosc; 2017 Jun; 85(6):1195-1207. PubMed ID: 27697445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Narrow-band imaging versus Lugol chromoendoscopy for esophageal squamous cell cancer screening in normal endoscopic practice: randomized controlled trial.
    Gruner M; Denis A; Masliah C; Amil M; Metivier-Cesbron E; Luet D; Kaasis M; Coron E; Le Rhun M; Lecleire S; Antonietti M; Legoux JL; Lefrou L; Renkes P; Tarreirias AL; Balian P; Rey P; Prost B; Cellier C; Rahmi G; Samaha E; Fratte S; Guerrier B; Landel V; Touzet S; Ponchon T; Pioche M
    Endoscopy; 2021 Jul; 53(7):674-682. PubMed ID: 32698233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Importance of upper digestive endoscopy using lugol dye solution for the diagnosis of superficial esophageal cancer and dysplasia in patients with head and neck neoplasms].
    Tincani AJ; Brandalise N; Andreollo NA; Lopes LR; Montes CG; Altemani A; Martins AS
    Arq Gastroenterol; 2000; 37(2):107-13. PubMed ID: 11144012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Routine endoscopic screening for synchronous esophageal neoplasm in patients with head and neck squamous cell carcinoma: a prospective study.
    Gong EJ; Kim DH; Ahn JY; Choi KS; Jung KW; Lee JH; Choi KD; Song HJ; Lee GH; Jung HY; Kim JH; Roh JL; Choi SH; Nam SY; Kim SY
    Dis Esophagus; 2016 Oct; 29(7):752-759. PubMed ID: 26471351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of esophageal lesions in patients with head and neck squamous cell carcinoma.
    Khoshbaten M; Naderpour M; Mohammadi G; Alipoor SH; Estakhri R; Fazeli Z
    Asian Pac J Cancer Prev; 2010; 11(4):863-5. PubMed ID: 21133592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lugol chromo-endoscopy versus narrow band imaging for endoscopic screening of esophageal squamous-cell carcinoma in patients with a history of cured esophageal cancer: a feasibility study.
    Lecleire S; Antonietti M; Iwanicki-Caron I; Duclos A; Lemoine F; Pessot FL; Michel P; Ducrotté P; Di Fiore F
    Dis Esophagus; 2011 Aug; 24(6):418-22. PubMed ID: 21309914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of unsedated transnasal endoscopy with white-light, flexible spectral imaging color enhancement, and lugol staining for esophageal cancer screening in high-risk patients.
    Arantes V; Albuquerque W; Salles JM; Freitas Dias CA; Alberti LR; Kahaleh M; Ferrari TC; Coelho LG
    J Clin Gastroenterol; 2013 Apr; 47(4):314-21. PubMed ID: 23059405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Routine image-enhanced endoscopic surveillance for metachronous esophageal squamous cell neoplasms in head and neck cancer patients.
    Ye YC; Wang YP; Chang TE; Wu PS; Hsin IF; Chen PH; Tai SK; Chu PY; Hou MC; Lu CL
    Esophagus; 2024 Apr; 21(2):131-140. PubMed ID: 38194013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-procedure oral administration of pronase improves efficacy of lugol chromoendoscopy in esophageal squamous cell carcinoma screening: a prospective, double-blinded, randomized, controlled trial.
    Zhao X; Guo M; Zhu S; Zhang L; Dong T; Luo H; Yu W; Zhu J; Fan X; Han Y; Liu Z
    Surg Endosc; 2023 Jun; 37(6):4421-4430. PubMed ID: 36781469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lugol chromoendoscopy as a diagnostic tool in so-called endoscopy-negative GERD.
    Yoshikawa I; Yamasaki M; Yamasaki T; Kume K; Otsuki M
    Gastrointest Endosc; 2005 Nov; 62(5):698-703; quiz 752, 754. PubMed ID: 16246682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolerability of magnifying narrow band imaging endoscopy for esophageal cancer screening.
    Yamasaki Y; Takenaka R; Hori K; Takemoto K; Kawano S; Kawahara Y; Okada H; Fujiki S; Yamamoto K
    World J Gastroenterol; 2015 Mar; 21(9):2793-9. PubMed ID: 25759551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of transnasal endoscopy for screening of esophageal squamous cell carcinoma in high-risk patients: yield rate, completion rate, and safety.
    Wang CH; Lee YC; Wang CP; Chen CC; Ko JY; Han ML; Chen TC; Lou PJ; Yang TL; Hsiao TY; Wu MS; Wang HP; Tseng PH
    Dig Endosc; 2014 Jan; 26(1):24-31. PubMed ID: 23551305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metachronous multiple esophageal squamous cell carcinomas and Lugol-voiding lesions after endoscopic mucosal resection.
    Urabe Y; Hiyama T; Tanaka S; Oka S; Yoshihara M; Arihiro K; Chayama K
    Endoscopy; 2009 Apr; 41(4):304-9. PubMed ID: 19340732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delineating the extent of esophageal squamous cell carcinoma.
    Kono M; Kanesaka T; Ishihara R; Kitamura M; Shoji A; Inoue T; Matsueda K; Miyake M; Waki K; Shimamoto Y; Fukuda H; Iwagami H; Matsuura N; Nakahira H; Shichijo S; Maekawa A; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Michida T; Nakatsuka SI; Fujiwara Y
    Esophagus; 2021 Oct; 18(4):790-796. PubMed ID: 34052934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.